New Director of Minimally Invasive Gynecologic Surgery Named
Gynecologic surgeon Dr. Ted Lee has joined NYU Langone as director of its Division of Minimally Invasive Gynecologic Surgery.
New Director of Nephrology at NYU Langone Health
David Charytan, MD, renowned expert in cardio-renal disease, named new division director of nephrology at NYU Langone.
New Director of Pediatric Neuro-Oncology Named
Dr. Jessica Clymer joins Hassenfeld Children’s Hospital at NYU Langone as director of pediatric neuro-oncology.
New Director to Lead Orthopedic Research
Thomas A. Einhorn, MD, is appointed Director of Clinical and Translational Research for NYU Langone’s Department of Orthopaedic Surgery. Learn More.
New Division of Oncological Rehabilitation Launches
Jonas M. Sokolof, DO, is leading the new Division of Oncological Rehabilitation to address cancer patients’ needs during and after treatment.
New DNA Sequencing Method Reveals Bacterial Defenses
NYU Langone researchers use new technology to read DNA code with enough accuracy to reveal how bacteria defeat antibiotics.
New Drug Atezolizumab Fights Advanced Bladder Cancer
A study led by a researcher at NYU Langone shows that the new drug atezolizumab is highly effective against advanced bladder cancer.
New Drug Combination Helps Stem Cell Therapy for Leukemia
NYU Langone study shows that a new drug combination prevents graft-versus-host disease in patients receiving stem cell transplants for leukemia.
New Drug Effective for Aggressive Form of Lung Cancer
NYU Langone medical oncologist Dr. Vamsidhar Velcheti discusses a new treatment for an aggressive form of non-small cell lung cancer.
New Drug Effective in Lung Cancers Caused by Genetic Error
NYU Langone research finds a new drug that can reduce the size of lung cancer tumors in people with a specific, disease-causing genetic change.